Century Therapeutics Inc (IPSC)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.11+0.96%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · IPSC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | 109.2 | 6.6 | 2.2 | 5.2 | — | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | — | — | — | — | — | 75.6 | 39.7 |
| Operating Income | (117.0) | (17.3) | (138.1) | (146.5) | (133.8) | (94.9) | (53.9) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | 0.5 | 1.0 | 1.3 | 0.4 |
| Other Non-Operating Income / Expenses | 7.1 | 7.6 | 13.4 | 11.8 | 3.0 | — | — |
| Asset Writedown | — | 6.8 | — | 16.4 | — | — | — |
| EBT, Incl. Unusual Items | — | (9.6) | (124.8) | (134.8) | (130.8) | (95.8) | (53.6) |
| Income Tax Expense | — | (0.1) | 1.8 | 1.9 | 0.1 | 0.0 | — |
| Net Income | |||||||
| Net Income | (109.8) | (9.6) | (126.6) | (136.7) | (130.9) | (95.8) | (53.6) |
| Per Share | |||||||
| Basic EPS | (0.53) | (0.14) | (1.61) | (2.30) | (2.27) | (2.96) | (7.16) |
| Diluted EPS | (0.53) | (0.14) | (1.61) | (2.30) | (2.96) | (2.96) | (7.16) |
| Basic Weighted Avg Shares | 205.8 | 86.6 | 78.6 | 59.3 | 57.8 | 32.4 | 7.5 |
| Diluted Weighted Avg Shares | 205.8 | 86.6 | 78.6 | 59.3 | 32.4 | 32.4 | 7.5 |
| Supplemental | |||||||
| EBIT | (117.0) | (17.3) | (138.1) | (146.5) | (133.8) | (94.9) | (53.9) |
| Effective Tax Rate | — | — | — | -1.4% | -0.1% | -0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.